Literature DB >> 24827732

Interaction of detergent sclerosants with cell membranes.

Kurosh Parsi1.   

Abstract

Commonly used detergent sclerosants including sodium tetradecyl sulphate (STS) and polidocanol (POL) are clinically used to induce endovascular fibrosis and vessel occlusion. They achieve this by lysing the endothelial lining of target vessels. These agents are surface active (surfactant) molecules that interfere with cell membranes. Surfactants have a striking similarity to the phospholipid molecules of the membrane lipid bilayer. By adsorbing at the cell membrane, surfactants disrupt the normal architecture of the lipid bilayer and reduce the surface tension. The outcome of this interaction is concentration dependent. At high enough concentrations, surfactants solubilise cell membranes resulting in cell lysis. At lower concentrations, these agents can induce a procoagulant negatively charged surface on the external aspect of the cell membrane. The interaction is also influenced by the ionic charge, molecular structure, pH and the chemical nature of the diluent (e.g. saline vs. water). The ionic charge of the surfactant molecule can influence the effect on plasma proteins and the protein contents of cell membranes. STS, an anionic detergent, denatures the tertiary complex of most proteins and in particular the clinically relevant clotting factors. By contrast, POL has no effect on proteins due to its non-ionic structure. These agents therefore exhibit remarkable differences in their interaction with lipid membranes, target cells and circulating proteins with potential implications in a range of clinical applications.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Sclerotherapy; biological membranes; detergent sclerosants; phospholipids; surfactants

Mesh:

Substances:

Year:  2014        PMID: 24827732     DOI: 10.1177/0268355514534648

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  8 in total

1.  The Addition of Lipid-Based Contrast Medium does not Inactivate the Detergent Sclerosant Sodium Tetradecyl Sulfate in-vitro.

Authors:  Charlotte L Oliver; Judy Brown; Mike Watkins; Ian McCafferty; Richard J Oliver
Journal:  Cardiovasc Intervent Radiol       Date:  2021-03-11       Impact factor: 2.740

Review 2.  Vascular anomalies of the head and neck: diagnosis and treatment.

Authors:  Frederic Bertino; Anna V Trofimova; Shenise N Gilyard; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2021-04-16

3.  Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.

Authors:  Matheus Bertanha; Rodrigo Gibin Jaldin; Regina Moura; Rafael Elias Farres Pimenta; Jamil Victor de Oliveira Mariúba; Carlos Eduardo Pinheiro Lúcio Filho; Giovana Piteri Alcantara; Carlos Roberto Padovani; Winston Bonetti Yoshida; Marcone Lima Sobreira
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

4.  In vitro oxidations of low-density lipoprotein and RAW 264.7 cells with lipophilic O(3P)-precursors.

Authors:  John T Petroff; Ankita Isor; Satyanarayana M Chintala; Carolyn J Albert; Jacob D Franke; David Weinstein; Sara M Omlid; Christopher K Arnatt; David A Ford; Ryan D McCulla
Journal:  RSC Adv       Date:  2020-07-15       Impact factor: 4.036

5.  Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?

Authors:  Mark S Whiteley; Laura K Taylor; Julie C King; Brittany E Hughes
Journal:  SAGE Open Med Case Rep       Date:  2021-03-09

6.  Treatment of facial hypertrophic capillary malformations with tumescent-assisted sclerotherapy.

Authors:  Mina Kang; Kurosh Parsi
Journal:  Australas J Dermatol       Date:  2022-04-12       Impact factor: 2.481

7.  Ocular Tolerability of Preservative-Free Tafluprost and Latanoprost: in vitro and in vivo Comparative Study.

Authors:  Yoshihiko Esaki; Atsushi Shimazaki; Pertti Pellinen
Journal:  Open Ophthalmol J       Date:  2016-05-31

Review 8.  Orbital infarction syndrome after multiple percutaneous sclerotherapy sessions for facial low-flow vascular malformation: A case report and literature review.

Authors:  Weng Sut Sio; Shwu-Huey Lee; I-Chia Liang
Journal:  Indian J Ophthalmol       Date:  2016-08       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.